Cargando…
Accelerating the development of a group A Streptococcus vaccine: an urgent public health need
Group A Streptococcus (GAS) infections cause substantial worldwide morbidity and mortality, mostly associated with suppurative complications such as pharyngitis, impetigo, and non-suppurative immune syndromes such as acute rheumatic fever, rheumatic heart disease, and acute post-streptococcal glomer...
Autores principales: | Excler, Jean-Louis, Kim, Jerome H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969273/ https://www.ncbi.nlm.nih.gov/pubmed/27489799 http://dx.doi.org/10.7774/cevr.2016.5.2.101 |
Ejemplares similares
-
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development
por: Frost, Hannah, et al.
Publicado: (2023) -
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics
por: Vekemans, Johan, et al.
Publicado: (2019) -
Global economic burden per episode for multiple diseases caused by group A Streptococcus
por: Lee, Jung-Seok, et al.
Publicado: (2023) -
The Streptococcus pyogenes vaccine landscape
por: Walkinshaw, Donald R., et al.
Publicado: (2023) -
Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management
por: Boquimpani, Carla Maria, et al.
Publicado: (2021)